GlassScriptPhysician profile
Kelli A Quercetti
NPI 1285954388
$1,174.94
in general payments reported to CMS, 2019-2025
16 companies · $97.80 in 2025
The $97.80 reported for 2025 was less than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $110 · 2021: $131 · 2022: $367 · 2023: $146 · 2024: $57.37 · 2025: $97.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $300.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $258.64 | 2019-2022 | |
| Optinose US, INC. | $239.31 | 2020-2024 | |
| Glaxosmithkline, LLC. | $175.91 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $137.03 | 2019-2023 | Dupixent |
| Axogen | $66.83 | 2020 | |
| Pfizer INC. | $60.21 | 2023-2024 | |
| Neurent Medical Limited | $49.64 | 2023 | Neuromark Radiofrequency Console, Neuromark Device |
| Biocryst US Sales Co., LLC | $32.75 | 2025 | Orladeyo |
| Kaleo, INC. | $31.46 | 2022 | |
| Genzyme Corporation | $24.99 | 2021 | |
| Abbvie INC. | $21.52 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.38 | 2024 | Cuvitru |
| Acclarent, INC | $17.20 | 2019 | |
| Olympus America INC. | $15.09 | 2019 | |
| Genentech USA, INC. | $13.49 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $11.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Quercetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.